Ophthalmologica · 2008 · 24 citations · 7 references
MedicineOphthalmologyPharmacotherapyOcular DiseaseOcular PharmacologyOphthalmic SurgeryMacular DegenerationRetinal PharmacotherapyRetinal Vascular DiseaseAnti-vegf Ocular TherapyIntravitreal Anti-vascular Endothelial Growth Factor TherapyMacular NeovascularizationNeovascular Macular DegenerationNeovascularizationOphthalmic Photodynamic TherapySeries Description
BACKGROUND: Intravitreal (IV) bevacizumab (Avastin(R), Roche), initially used for the off-label treatment of neovascular age-related macular degeneration (AMD), has extended itself to treat various ocular pathologies such as choroidal neovascularization not associated to AMD. METHODS: IV bevacizumab 1,25 mg (Avastin) was used in the treatment of choroidal neovascularization (CNV) in 6 eyes of 5 patients with angioid streaks. All cases had a history of photodynamic treatment (PDT) or laser treatment and all showed progressive worsening despite the use of these therapies. RESULTS: After injection patients were followed up at nearly 2-month intervals. IV Avastin was repeated in case of recurrence. Three eyes were treated combining PDT and IV Avastin. Cases were followed up for 7-14 months. All patients needed more IV injections. Five out of 6 eyes showed an improvement of BCVA and a slight reduction of leakage and size with FA. CONCLUSION: This small series suggests that IV Avastin might be useful in the treatment of CNV due to AS.
7
OUTCOME OF CHOROIDAL NEOVASCULARIZATION IN ANGIOID STREAKS AFTER PHOTODYNAMIC THERAPY
Ugo Menchini, Gianni Virgili, Ugo Introini et al. · Retina · 2004 · 87 citations
Macular Degeneration in Angioid Streaks
Ahmad M. Mansour, Jerry A. Shields, William H. Annesley et al. · Ophthalmologica · 2010 · 46 citations